1 Recommendations
KEYWORDS: miraq, graft, cost, flow, cabg, surgery, patients, veriq, costs, grafts, clinical, assessment, pulsatility index, index, pulsatility

and revised as necessary to achieve acceptable blood flow. 2.4 The cost of the MiraQ system stated in the sponsor's submission includes £32,000 for the VeriQ 2011 console, and £1,582 for each PS probe. These costs were updated in the 2017 revision of the cost model to £34,000 for the cardiac MCQ0 console and £1,481 for each probe. [2018] These costs were updated again in the 2021 revision of the cost model, because the MiraQ console and PS probe increased in price to £35,955 and £1,720, respectively. The annual maintenance cost (assuming a 10-year life span) reduced from £1,800 to £1,369.80. [2022] 2.5 The claimed benefits of the MiraQ system in the case for adoption presented by the manufacturer are: • improved outcomes of revascularisation procedures by reducing the risk of early graft failure and adverse events • reduced hospital stay for some patients by reducing the incidence of complications during and after surgery • reduced numbers of repeat procedures and treatments for postoperative complications. Current management 2.6 Coronary artery disease is a common cause of symptoms, disability and death. It is caused by atherosclerosis, which leads to stenosis or occlusion of the coronary arteries. NICE's guideline on stable angina
